Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population
- 1 September 1999
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 146 (1) , 133-140
- https://doi.org/10.1016/s0021-9150(99)00111-2
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Defects in human methionine synthase in cblG patientsHuman Molecular Genetics, 1996
- Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C 677 T MutationArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Molecular basis of phenotype expression in homocystinuriaJournal of Inherited Metabolic Disease, 1994
- Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Pharmacokinetics of extracellular-superoxide dismutase in the vascular systemFree Radical Biology & Medicine, 1993
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine‐homocysteine mixed disulphideEuropean Journal of Clinical Investigation, 1979
- The pathogenesis of coronary artery disease. A possible role for methionine metabolism.Journal of Clinical Investigation, 1976